$ADTX Income Statement | Understand Stock

$ADTX

$0.01 +$0.00 (0.0%) Close

$ADTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
REVENUE
Sales
Cost of goods sold
Gross profit (loss)
OPERATING EXPENSES
General and administrative expenses $0 and $33,071in stock-based compensation, respectively
Research and development $10,000 and $6,712,663 in stock-based compensation, respectively
Sales and marketing, includes $1,023,045, and $0 in stock-based compensation, respectively
Impairment on notes receivable
Sales and marketing $473,311 and $0 in stock-based compensation, respectively
Total operating expenses

NET LOSS FROM OPERATIONS
Interest expense
OTHER INCOME (EXPENSE)
Other income
Interest expense
Interest income
Amortization of debt discount
Gain on note exchange agreement
Gain (loss) on note exchange agreement
Change in fair value of derivative liability
Change in fair value of Evofem warrants
Impairment of Evofem F-1 Preferred Stock
Bargain purchase gain from purchase of Evofem convertible notes
Impairment of fixed assets
Total other expense
Net loss before income taxes

NET LOSS
Other Comprehensive Loss:
Change in valuation of Evofem note
TOTAL COMPREHENSIVE LOSS
Deemed Dividends
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST
NET LOSS ATTRIBUTABLE TO ADITXT, INC. & SUBSIDIARIES
Net loss per share - basic and diluted (in Dollars per share)
Weighted average number of shares outstanding during the period - basic and diluted (in Shares)
Implied Dividends
Deemed Dividend
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
Net loss per share, basic (in Dollars per share)
Net loss per share, diluted (in Dollars per share)
Weighted average number of shares outstanding during the period, basic (in Shares)
Weighted average number of shares outstanding during the period, diluted (in Shares)

Comments